Tepotinib outcomes according to prior therapies in patients with MET exon 14 (METex14) skipping NSCLC Meeting Abstract
| Authors: | Smit, E. F.; Garassino, M. C.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Mazieres, J.; Cortot, A.; Raskin, J.; Thomas, M.; Viteri Ramirez, S. V.; Berghoff, K.; Bruns, R.; Otto, G. P.; Paik, P. K. |
| Abstract Title: | Tepotinib outcomes according to prior therapies in patients with MET exon 14 (METex14) skipping NSCLC |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1002 |
| End Page: | S1003 |
| Language: | English |
| ACCESSION: | WOS:000866211601252 |
| DOI: | 10.1016/j.annonc.2022.07.1112 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 985P -- Source: Wos |
